Smoking Tied to Increased Risk for Type 2 Diabetes
WEDNESDAY, Sept. 17, 2025 -- Smoking increases the risk for type 2 diabetes across all disease subtypes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 15 to 19 in Vienna.
Emmy Keysendal, from the Karolinska Institutet in Stockholm, and colleagues investigated whether the influence of smoking on diabetes risk varied by subtype and explored interaction with genetic susceptibility to diabetes, insulin resistance (IR), and insulin secretion (IS). The analysis included 3,325 people with incident type 2 diabetes (across two cohorts) and 3,897 controls.
The researchers found that ever versus never smokers had an increased risk for severe insulin-resistant diabetes (SIRD; relative risk [RR], 2.15). A weaker trend was seen for severe insulin-deficient diabetes (SIDD; RR, 1.20; 95 percent confidence interval [CI], 0.98 to 1.47), mild obesity-related diabetes (MOD; RR, 1.29; 95 percent CI, 1.06 to 1.57) and mild age-related diabetes (MARD; RR, 1.27; 95 percent CI, 1.12 to 1.44). Smoking accounted for a higher proportion of SIRD cases (35.3 percent) than for SIDD (13.1 percent), MOD (13.0 percent), and MARD (13.9 percent) subtypes. Across all subgroups, heavy smoking (≥15 pack-years versus never) was associated with a higher risk. There was an additive interaction between heavy smoking and type 2 diabetes genetic risk score (GRS) and impaired insulin secretion GRS, but not insulin resistance GRS, on the risk for both SIDD and SIRD.
"Our findings emphasize the importance of smoking cessation in the prevention of type 2 diabetes," Keysendal said in a statement. "They also indicate that genetic information may help identify individuals most likely to benefit from extra support in stopping smoking."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Weight-Loss Surgery Bests Medical Weight Management for Obesity-Related Risk Mitigation
WEDNESDAY, Sept. 17, 2025 -- Bariatric surgery is associated with a significantly lower risk for developing major metabolic comorbidities compared with a medical weight management...
Parent-Focused Interventions Do Not Prevent Obesity at Age 24 Months
TUESDAY, Sept. 16, 2025 -- Parent-focused behavioral interventions seem to be insufficient for preventing obesity at age 24 months, according to a review published online Sept. 10...
Half Discontinue Semaglutide for Weight Loss Within One Year
TUESDAY, Sept. 16, 2025 -- Half of adults who start semaglutide for weight loss discontinue within a year, according to a study presented at the annual meeting of the European...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.